Vinati Organics Limited (VINATIORGA) AI Stock Analysis

• Market Cap: ₹143.75B
• Dividend Yield: 0.48%
• Average Volume (3M): 1.59K
• Price to Earnings (P/E): 40.8
• Beta (1Y): 0.88
• Revenue Growth: 8.96%
• EPS Growth: 17.70%
• Country: IN
• Employees: 1,279
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 9.70
• Shares Outstanding: 103,665,634
• 10 Day Avg. Volume: 1,522
• 30 Day Avg. Volume: 1,587
• PEG Ratio: 1.59
• Price to Book (P/B): 5.87
• Price to Sales (P/S): 7.33
• P/FCF Ratio: -389.88
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹1,950.00
• Price Target Upside: 21.83% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 44.23
• Revenue Forecast (FY): ₹22.96B

• Rating: 69 Neutral
• Price Target: ₹1,518.00 ▼(-5.16% Downside)
• Action: Reiterated Date: 10/02/25
• Date: Action: Reiterated 10/02/25

Vinati Organics Limited demonstrates strong financial performance with robust revenue growth and profitability, which is the most significant factor in the overall score. However, the high P/E ratio and modest dividend yield suggest a high valuation, which may limit immediate investment appeal. Technical indicators show a stable but non-trending market position, contributing to a moderate overall score.

Positive Factors

High and Sustainable Margins

Consistently strong gross, EBIT and net margins reflect pricing power in niche molecules and efficient manufacturing. High margins are durable in specialty chemicals because customer qualification and technical specs support premium pricing and protect profitability over the next 2–6 months.

Very Low Leverage and Strong Capital Structure

Extremely low debt and a high equity ratio give balance-sheet flexibility to fund growth or withstand industry cyclicality. A 14.5% ROE shows effective capital use; this structural strength reduces financing risk and supports sustained investment capacity in the medium term.

Niche B2B Specialty-Chemicals Business Model

Focus on specialized intermediates (IBB, ATBS) and B2B customer qualification creates sticky, repeat demand and technical barriers to entry. This business model supports stable volumes, long-term customer relationships, and durable competitive advantage versus commodity producers.

Negative Factors

Negative Free Cash Flow from High CapEx

Persistently negative free cash flow driven by elevated capital expenditures constrains internal funding for expansions, dividends or debt reduction. Even with solid operating cash conversion, sustained capex needs can limit cash flexibility and strategic optionality over several quarters.

Earnings Sensitive to Volumes and Product Mix

Profitability relies on capacity utilization and higher-margin product mix; declines in volumes or shifts to lower-margin products can rapidly compress margins. Exposure to input-cost spreads and downstream demand cycles creates structural earnings variability over the medium term.

Export FX Exposure and Limited Customer/Geography Disclosure

Reliance on exports introduces currency and cross-border demand risks; the lack of disclosed customer/geography breakdown increases uncertainty about client concentration. FX swings or loss of a major buyer could materially affect revenue stability in coming months.

Vinati Organics Limited Business Overview & Revenue Model

Company Description

Vinati Organics Limited, a specialty chemical company, engages in the manufacture and sale of specialty organic intermediaries and monomers primarily in India. It offers specialty monomers comprising 2-acrylamido 2-methylpropane sulphonic acid, sodium salt of 2-acrylamido-2-methylpropane sulphonic acid, N-tertiary butyl acrylamide, and N-tertiary octyl acrylamide. The company also provides aromatics, including isobutyl benzene, which is used as raw material for manufacturing ibuprofen, an anti-inflammatory analgesic bulk drug; normal butyl benzene that is used as compound for chemical synthesis of a number of intermediates; hexenes, which is used as low boiling point solvents, as thinners, for solvent extractions, in tire retreading, as octane booster for gasoline, and for manufacturing C-5/C-6 aliphatic petroleum; and butyl phenols. In addition, it offers methyl-4-tert butyl benzoate; para tertiary butyl benzoic acid; isobutylene, a carbon branched olefin; methanol for use as a chemical intermediate; high purity methyl tertiary butyl ether that is used as a solvent in organic synthesis, pharmaceutical synthesis, and synthesis of Grignard's reagent; tertiary-butylamine; and polymers for use in industries, such as construction, ceramics, oil drilling, mining, leather, and paper. The company also exports its products primarily to the United States, Europe, and Asia. Vinati Organics Limited was incorporated in 1989 and is based in Mumbai, India.

How the Company Makes Money

Vinati Organics makes money primarily by manufacturing and selling specialty chemical products (mostly B2B) to domestic and international customers that use these chemicals as intermediates in their own production. The core revenue stream is product sales revenue, earned by delivering contracted/spot volumes of its key products (notably IBB and ATBS) and other specialty chemicals to end-use industries such as pharmaceuticals (e.g., intermediates used in drug manufacturing), polymers and plastics, water treatment, oil & gas chemicals, coatings, adhesives, and other industrial applications where these monomers/intermediates are required. Earnings are driven by (1) sales volumes and capacity utilization at its manufacturing facilities, (2) product mix (higher contribution from higher-margin niche products), and (3) spreads between selling prices and input/raw-material plus energy and logistics costs. Because it operates in specialty chemicals, the business typically benefits from customer qualification and long-term supply relationships where consistent quality and reliable supply can support repeat orders and relatively stable demand for specific molecules. Export sales (where applicable) contribute to revenue and can add foreign-currency exposure; however, the specific split by geography, named customer contracts, or partnership details are null.

Vinati Organics Limited Financial Statement Overview

Summary

Vinati Organics Limited exhibits strong financial performance with robust revenue growth and profitability, supported by a stable balance sheet with low leverage. Despite challenges in free cash flow due to high capital expenditures, the company maintains healthy operational cash flow. Overall, the financial health is robust, with potential for continued growth and expansion.

Income Statement

Vinati Organics Limited demonstrates a robust income statement with strong revenue growth and profitability. The gross profit margin for 2025 is approximately 40.1%, indicating efficient cost management. The net profit margin has also improved to 18%, reflecting enhanced profitability. Notably, the revenue growth rate from 2024 to 2025 is 18.9%, showcasing significant business expansion. Additionally, the EBIT and EBITDA margins stand at 33.9% and 25.8%, respectively, highlighting strong operational efficiency.

Balance Sheet

The balance sheet of Vinati Organics Limited is stable with a low debt-to-equity ratio of 0.02, indicating minimal leverage and reduced financial risk. The return on equity (ROE) for 2025 is 14.5%, showing effective utilization of shareholder funds to generate profits. The equity ratio is high at 85.2%, reflecting a strong capital structure with a significant portion of assets financed by equity. Overall, the balance sheet suggests financial stability and low risk.

Cash Flow

Cash flow analysis reveals a mixed scenario. The free cash flow has significantly declined from -719.1 million in 2024 to -420.5 million in 2025, but the operating cash flow to net income ratio is favorable at 1.13, indicating good cash generation from operations relative to net income. However, the free cash flow to net income ratio is negative due to high capital expenditures, suggesting potential constraints on cash availability for investment and expansion.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	22.62B	22.36B	18.90B	20.65B	16.13B	9.42B
Gross Profit	9.58B	9.01B	5.49B	10.01B	7.52B	5.55B
EBITDA	6.79B	5.81B	5.10B	6.25B	4.96B	3.79B
Net Income	4.36B	4.05B	3.23B	4.19B	3.47B	2.69B
Balance Sheet
Total Assets	33.04B	32.79B	28.40B	25.47B	20.90B	17.34B
Cash, Cash Equivalents and Short-Term Investments	1.30B	139.30M	333.80M	2.03B	142.48M	1.88B
Total Debt	0.00	626.30M	46.46M	2.01M	183.99M	20.25M
Total Liabilities	3.70B	4.86B	3.82B	3.29B	2.62B	1.90B
Stockholders Equity	29.34B	27.93B	24.62B	22.18B	18.28B	15.43B
Cash Flow
Free Cash Flow	2.30B	-420.50M	-719.14M	2.99B	-471.06M	1.36B
Operating Cash Flow	3.58B	4.58B	3.32B	5.77B	1.27B	2.19B
Investing Cash Flow	-923.80M	-4.43B	-3.48B	-3.67B	-2.55B	-1.98B
Financing Cash Flow	-1.41B	-155.80M	-1.08B	-859.60M	-465.42M	-30.98M

Vinati Organics Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1600.55
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VINATIORGA, the sentiment is Negative. The current price of 1600.55 is above the 20-day moving average (MA) of 1424.10, above the 50-day MA of 1493.11, and below the 200-day MA of 1673.23, indicating a bearish trend. The MACD of -31.44 indicates Negative momentum. The RSI at 40.72 is Neutral, neither overbought nor oversold. The STOCH value of 69.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VINATIORGA.

Vinati Organics Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VINATIORGA	69 Neutral	₹143.75B	40.85	―	0.48%	8.96%	17.70%
ATUL	64 Neutral	₹183.69B	28.12	―	0.41%	16.46%	43.59%
NAVINFLUOR	64 Neutral	₹313.87B	40.91	―	0.23%	30.05%	70.18%
AARTIIND	63 Neutral	₹154.79B	25.48	―	0.26%	8.26%	-34.62%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
BASF	59 Neutral	₹143.85B	40.15	―	0.51%	0.43%	-42.29%
DEEPAKNTR	52 Neutral	₹189.70B	59.14	―	0.44%	-7.50%	-37.67%

Vinati Organics Limited Corporate Events

Vinati Organics Publishes Q3 and Nine-Month FY26 Unaudited Results in Newspapers

Vinati Organics Limited has published its unaudited standalone and consolidated financial results for the third quarter and nine months ended 31 December 2025, following approval by its board on 31 January 2026. In line with SEBI’s listing and disclosure regulations, the company has released result extracts in the Business Standard (English) and Sakal (Marathi) on 2 February 2026, included a QR code and web link directing investors to the full financial statements, and simultaneously uploaded the information to its website, underscoring its focus on regulatory compliance and transparent communication with shareholders and market participants.